F.J.M. van Breukelen

INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)

F.J.M. van Breukelen, O.L.M. Bijvoet, A.T. van Oosterom · The Lancet · 1979 · 172 citations

Bone Disease, Medicinal Chemistry, Medicine +6

Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium

F.J.M. van Breukelen, O. L. M. Bijvoet, W. B. Frijlink et al. · Calcified Tissue International · 1982 · 68 citations

Serum Calcium, Electrolyte Disorder, Amino-hydroxypropylidene Bisphosphonate +8

Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative group

F.J.M. van Breukelen, K. Mattson, Giuseppe Giaccone et al. · European Journal of Cancer and Clinical Oncology · 1991 · 51 citations

Malignant Pleural Mesothelioma, Malignant Disease, Medicine +7

Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life

W. Bakker, A.T. van Oosterom, N.K. Aaronson et al. · European Journal of Cancer and Clinical Oncology · 1986 · 28 citations

Oncology, Medicine, Cancer Management +8